Objective: Our purpose is to examine the effect of D2/D3 agonists on semantic priming.
D
opamine is distributed to the frontal cortex via the mesocortical pathway from the ventral tegmentum in the midbrain. In addition to its well-known motor effects, the dopaminergic system also has effects on processing of semantic information. Kischka et al 1 showed that in healthy individuals, semantic priming allowed more rapid recognition of words in a lexical decision task if the prime was directly related (summer-winter) or indirectly related (summer-snow) to the target word at a stimulus onset asynchrony (SOA) of 700 ms (when subjects are asked whether the second word is a word 700 ms after presentation of the first). However, after administration of 100 mg L-dopa, semantic priming no longer occurred for indirectly related words. This was believed to result from a restriction of the semantic network due to dopamine. In another study on healthy volunteers, Angwin et al 2 found a loss of both direct and indirect semantic priming with 100 mg L-dopa at an SOA of 500 ms. Direct and indirect semantic priming was present in both drug conditions at shorter SOAs (250 ms), and no direct or indirect semantic priming was present in either drug condition at longer SOAs (1200 ms). However, as L-dopa affects all dopamine receptors, less is known about the specific dopaminergic receptors mediating the semantic priming effect of L-dopa.
Patients with Parkinson disease (PD) have degeneration of the dopaminergic system. PD patients show abnormal processing of semantic information with slower than normal activation and decay rates. A significant facilitation and the absence of inhibition at longer SOAs (500 to 2000 ms) is found in the setting of a low proportion of related words as compared with unrelated words in the priming experiment, whereas the facilitation in normals occurs at SOAs of as early as 250 ms, but not at the higher SOAs. 3 This is proposed to be due to a decreased signal to noise ratio associated with decreased dopamine due to PD that slows semantic activation and interferes with the focusing of limited attentional resources. However, varying results have been found with differing task parameters in PD patients. 4, 5 Regardless of the specific effects in PD, these effects in PD patients also support the idea that dopamine has a modulatory role in the semantic network. However, as described above, less is known about the specific receptors involved with modulation of semantic processing. Recent evidence has suggested that in healthy individuals, dopaminergic modulation of semantic priming occurs only with agents that affect D1 receptors. 6 However, as baseline levels of dopamine are normal in such individuals, it is unknown how this may manifest in PD patients where dopamine levels are decreased.
Therefore, to better understand how dopamine regulates semantic activation in PD, the aim of this study is to begin to determine which dopamine receptors modulate semantic activation by examining the effects of various dopaminergic drugs on semantic priming in PD patients.
EXPERIMENTAL DESIGN AND METHODS

Subjects
Ten female and 5 male nondemented Parkinson disease patients on monotherapy for dopaminergic agents were recruited [average age 61.5 ± 9.1 (SD) y]. Eight subjects were taking pramipexole (average dose = 1.03 ± 0.3 mg) or ropinirole (average dose = 6.0 ± 0.0 mg) as monotherapy, which are D 2 and D 3 agonists, 7 and 7 were taking carbidopa/L-dopa (average dose L-dopa = 120 ± 52 mg) as monotherapy, which, as its centrally active ingredient (L-dopa) converts to dopamine, affects D 1 , D 2 , and D 3 receptors in the brain. Severity did not differ between the 2 groups [mean Hoehn and Yahr 8 scores for D 2 and D 3 = 2.21 ± 0.27, for L-dopa = 2.31 ± 0.26, t(13) = 0.72, P = 0.48, not significant]. The subjects were tested immediately before and 60 minutes after they received their first morning regular daily dosage, allowing for peak concentrations of all 3 drugs to be reached. 7 In compliance with the Institutional Review Board of The Ohio State University, all subjects gave signed consent and subjects with a reported history of learning disabilities such as dyslexia were excluded. English was the native language for all subjects.
Priming Paradigm
Prime + Target Blank Screen (200 ms) (500 ms) (1000 ms) (1000 ms)
Each subject performed 2 distinct sets of a lexical decision paradigm consisting of 30 randomly presented pairs each of closely (C) related words (eg, farmer-field), distantly (D) related words (eg, summer-snow), and unrelated (N) words (eg, water-computer), mixed with 60 pairs where the second word is a nonword (NW), using stimuli derived from our previous research. 9 One set was presented before taking their medication and the other set 1 hour after taking their AM dose of medication.
For each test, the subjects were presented a set of the stimulus word pairs with an SOA of 700 ms (as per Kischka et al 1 ). They were asked to press a button as quickly as possible when they recognized whether the second word in the pair is a real English word or not a word. Response times and accuracy were recorded using SuperLab (Version 2.0 Cedrus Corp, San Pedro, CA).
Initial analysis of variance was performed to compare each pair of semantic distances before and after treatment for each drug group to test for interaction effects. On the basis of results of the analysis of variance and the specific hypothesis of a D1 effect based on previous research, 6 and to examine the specific priming effects, subsequent t tests were used to compare response latencies within subject between closely, distantly, and unrelated word pairs to define the semantic priming effects before drug administration. This was then repeated after drug administration for each drug group, to determine which drug yielded differing patterns of priming effects before and after drug.
RESULTS
For L-dopa, a weak trend was observed for an interaction effect between semantic distance and treatment for closely and distantly related words [F(1,203) = 2.07, P = 0.152]. To examine the specific priming effects, due to previous studies suggesting a D1 effect in healthy subjects, 6 closely related word pairs were recognized significantly faster than the unrelated [t(203) = 3.502, P = 0.001] and distantly related [t(205) = 3.143, P = 0.002] word pairs before drug (mean response latencies: closely = 1042 ms, distantly = 1159 ms, and unrelated = 1185 ms). Therefore, before drug, priming occurred only with closely related words. Closely related word pairs remained faster than the unrelated word pairs [t(201) = 2.012, P = 0.046], but not the distantly related word pairs after drug [t(207) = 1.028, P = 0.305] (mean response latencies: closely = 1096 ms, distantly = 1148 ms, and unrelated = 1178 ms), suggesting the potential of an effect of L-dopa on semantic priming in PD patients (Fig. 1) .
One subject taking a D2 and D3 agonist was excluded from further analysis because of consistent inability to perform the button press within 2 seconds (average latency >2 s). For the remaining subjects taking pramipexole and ropinirole, no interaction effect was observed between semantic distance and treatment for any combination of semantic distances. To examine specific priming effects, closely related word pairs were significantly faster than unrelated [t(175) = 2.240, P = 0.026] and distantly related [t(174) = 2.599, P = 0.010] word pairs before the consumption of drug (mean response latencies: closely = 895 ms, distantly = 993 ms, and unrelated = 971 ms). Therefore, before drug, as with before L-dopa, priming occurred only with closely related words. The closely related words remained significantly faster than unrelated [t(200) = 2.704, P = 0.007] and distantly related [t(199) = 2.175, P = 0.031] word pairs after drug administration (mean response latencies: closely = 743 ms, distantly = 803 ms, and unrelated = 820 ms), further supporting a lack of effect of these dopaminergic agonists on semantic priming. Whereas the overall response rate was faster after drug, the lack of a change in the relationship between the semantic conditions suggests no effect on semantic priming by these drugs in Parkinson disease patients (Fig. 1) . Incorrect responses were rare in all conditions (<5% for each condition).
DISCUSSION
L-dopa appeared to have some modulatory role in the semantic priming effect, whereas pramipexole and ropinirole had no such effect.
As described above L-dopa affects D1, D2, and D3 dopamine receptors and pramipexole and ropinirole specifically affect D2 and D3 dopamine receptors. All 3 receptors are present on cortical neurons. D1 receptors are known to be in the zona compacta of the substantia nigra and are presynaptically located on striatal axons coming from the cortical neurons. These receptors are excitatory in nature. Therefore, it might be expected that the modulatory effect of dopamine on the semantic network would be mediated by this excitatory system. In the cerebral cortex, D2 and D3 receptors are inhibitory. D2 receptors are known to be located postsynaptically on striatal neurons and presynaptically on axons in the substantia nigra originating from neurons in the basal ganglia. 10 Research in animal models has shown varying effects of different dopaminergic agents affecting various receptor subtypes on set-shifting tasks. 11 In particular, agonists of both D1 and D2 had no effect on set shifting whereas D2 antagonists impaired set shifting in rodents. N-methyl-D-aspartate receptors in the prefrontal cortex and the nucleus accumbens core also interact to affect set shifting.
12,13 D2 antagonists have also been shown to impair set shifting in human volunteers. 14 A computational model has been proposed wherein phasic stimulation of D2 receptors in the striatum drives flexible adaptation of cognitive representations maintained by the prefrontal cortex. 15 This is in contrast to our study, comparing L-dopa to pramipexole and ropinirole (which act on D2 and D3 receptors), which suggests that the D1 dopamine receptor may be involved in semantic priming effects. Therefore, the receptors mediating dopaminergic effects on set shifting seem to be distinct from those mediating semantic priming effects. However, due to L-dopa's effects on all dopamine receptors, and its conversion to norepinephrine, we cannot exclude the possibility that any effect of priming due to L-dopa in this study is resulting from other dopaminergic or noradrenergic receptors. The previous research examining dopaminergic agonists with and without D1 effects in healthy controls, 6 though, does suggest that our findings may have also been due to D1 effects. The role of N-methyl-D-aspartate activity in semantic priming is unknown.
The priming effect may differ in Parkinson disease patients. As described above, Arnott et al 3 found in Parkinson's subjects that semantic activation in priming emerged at 500 ms and persisted, where as in control subjects semantic activation emerged at 200 ms was degraded by 500 ms. These findings were proposed to be consistent with the decreased signal-to-noise ratio in semantic processing demonstrated by Parkinson's patients and the subsequent improvement in semantic priming effects with the administration of dopamine. Previous research has also shown that the interactions between dopaminergic agonists and Parkinson disease and their effect on cognition is a highly complex relationship for cognitive flexibility and working memory tasks. 16 In our study, both direct (closely vs. unrelated words) and indirect (distantly vs. unrelated words) priming were examined. Where in normal patients both types of priming effects were observed, 1 there was no indirect priming effect in Parkinson disease patients in our study before drug (distantly vs. unrelated revealed no difference under any condition). This is of interest because increased dopamine has been proposed to restrict the semantic network in previous priming experiments, since Kischka et al, 1 as described above, found that by increasing the level of dopamine in normal patients through the administration of L-dopa, the indirect priming effect was reduced significantly. With this in mind, one might expect that in the dopamine depleted state of Parkinsonism, an increase in the indirect priming effect would be seen in untreated patients. However, our study demonstrated an absence of the indirect priming effect in the decreased dopamine state of Parkinson's patients, perhaps due to the effects of delayed semantic activation in the indirect condition. This further raises the suspicion that the drug effects on priming observed in Parkinson disease may also be different from what would be observed in normal individuals. This warrants further investigation. 
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